Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study

NCT06925685 is registered in ClinicalTrials.gov with Allogene Therapeutics as lead sponsor.

NCT NCT06925685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study
Lead sponsor
Allogene Therapeutics
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 31, 2025
Completion date
January 31, 2039
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies, solid tumors